1-3 of 3
Thierry Lambert, MD
Close
Sort by
Journal Articles

FVIII Recovery after a Single Infusion of Recalibrated ReFacto in 14 Severe Hemophilia A Patients.

Thierry Lambert, MD, Claude Guérois, MD, Valerie Gay, MD, Natalie Stieltjes, MD, Marie-Anne Bertrand, MD, Annie Derlon, MD, Marianne Sigaud, MD, Abel Hassoun, MD, Claude Négrier, MD, Brigitte Coatmelec, MD, Marie Dreyfus, MD, Arnaud Dubanchet, MD
Journal: Blood
Blood (2005) 106 (11): 2143.
https://doi.org/10.1182/blood.V106.11.2143.2143
Published: 2005
Journal Articles

A New Formulation of Recombinant Human Factor IX Is Bioequivalent to BeneFIX: A Double-Blind, Randomized, Crossover Pharmacokinetic and Open-Label Safety and Efficacy Study.

Jerry Sherman Powell, MD, Thierry Lambert, MD, F. Hernández Navarro, MD, Michael Recht, MD, Sharon T. Sullivan, PhD, Chandrasekhar Udata, PhD, Leslie C. Lilly, BSN, RN, David A. Roth, MD, The rFIX-R Study Group
Journal: Blood
Blood (2005) 106 (11): 4076.
https://doi.org/10.1182/blood.V106.11.4076.4076
Published: 2005
Journal Articles

Immune Tolerance Resulting in a Dramatic Clinical Improvement in a High-Responding Inhibitor Hemophilia A Patient Using Immunosuppression with Mycofenolate Mofetil and a Factor VIII Concentrate Containing Von Willebrand Factor.

Thierry Lambert, MD, Cécile Goujard, MD, Anne Rafowicz, MD, Benoît Guillet, MD, Yacine Taoufik, MD, Marie Dreyfus
Journal: Blood
Blood (2005) 106 (11): 3220.
https://doi.org/10.1182/blood.V106.11.3220.3220
Published: 2005